• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肿瘤微生物组失调和肿瘤相关成纤维细胞中 在青年结直肠癌中的异常定植。

Dysbiosis of human tumor microbiome and aberrant residence of in tumor-associated fibroblasts in young-onset colorectal cancer.

机构信息

Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Shanghai Minimally Invasive Surgery Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

出版信息

Front Immunol. 2022 Sep 2;13:1008975. doi: 10.3389/fimmu.2022.1008975. eCollection 2022.

DOI:10.3389/fimmu.2022.1008975
PMID:36119074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9481283/
Abstract

Colorectal cancer (CRC) is the third most common form of cancer, and the incidence of sporadic young-onset colorectal cancer (yCRC) has been increasing. Microbiota residing in the tumor microenvironment are emerging tumor components. The colonic microbiome differs between patients with CRC and healthy controls; however, few studies have investigated the role of the tumor microbiota in disease diagnosis and tumorigenesis of yCRC. We performed 16S rRNA sequencing analysis to identify the microbiome in CRC and found that tumor microbial diversity decreased in yCRC. Proteobacteria and Firmicutes were the most abundant phyla in all CRC samples, and and were the key microbiota in the yCRC group. Correlation analysis revealed that co-occurred with various pro-tumor microbial taxa, including Bacteroidia, Gammaproteobacteria, and . An independent cohort was used to validate the results. The in CRC was co-localized with cancer-associated fibroblasts and activated the TLR2/NF-κB pathway and reduces CD8+ T lymphocyte infiltration in CRC microenvironment. This study suggests that tumoral microbiota plays an important role in promoting tumorigenesis and therefore has potential as a promising non-invasive tool and intervention target for anti-tumor therapy.

摘要

结直肠癌(CRC)是第三大常见癌症,散发性早发性结直肠癌(yCRC)的发病率一直在增加。驻留在肿瘤微环境中的微生物群是新兴的肿瘤成分。CRC 患者和健康对照者的结肠微生物群不同;然而,很少有研究调查肿瘤微生物群在 yCRC 疾病诊断和肿瘤发生中的作用。我们进行了 16S rRNA 测序分析,以鉴定 CRC 中的微生物组,发现 yCRC 中的肿瘤微生物多样性降低。变形菌门和厚壁菌门是所有 CRC 样本中最丰富的门,和 是 yCRC 组中的关键微生物群。相关性分析表明 与各种促肿瘤微生物类群共同存在,包括拟杆菌门、γ-变形菌门和。使用独立队列验证了结果。CRC 中的 与癌症相关成纤维细胞共定位,并激活 TLR2/NF-κB 通路,减少 CRC 微环境中 CD8+T 淋巴细胞浸润。这项研究表明,肿瘤微生物群在促进肿瘤发生中起着重要作用,因此具有作为有前途的非侵入性工具和抗肿瘤治疗干预靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/8e184f86cbd6/fimmu-13-1008975-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/a59bf61c63d4/fimmu-13-1008975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/90594208727d/fimmu-13-1008975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/846f1ab1a516/fimmu-13-1008975-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/e695d37da895/fimmu-13-1008975-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/7ac144eb8374/fimmu-13-1008975-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/aaa26d1e0772/fimmu-13-1008975-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/8e184f86cbd6/fimmu-13-1008975-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/a59bf61c63d4/fimmu-13-1008975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/90594208727d/fimmu-13-1008975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/846f1ab1a516/fimmu-13-1008975-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/e695d37da895/fimmu-13-1008975-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/7ac144eb8374/fimmu-13-1008975-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/aaa26d1e0772/fimmu-13-1008975-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb27/9481283/8e184f86cbd6/fimmu-13-1008975-g007.jpg

相似文献

1
Dysbiosis of human tumor microbiome and aberrant residence of in tumor-associated fibroblasts in young-onset colorectal cancer.人肿瘤微生物组失调和肿瘤相关成纤维细胞中 在青年结直肠癌中的异常定植。
Front Immunol. 2022 Sep 2;13:1008975. doi: 10.3389/fimmu.2022.1008975. eCollection 2022.
2
Dysbiosis of human gut microbiome in young-onset colorectal cancer.青年期结直肠癌患者的肠道微生物群失调。
Nat Commun. 2021 Nov 19;12(1):6757. doi: 10.1038/s41467-021-27112-y.
3
Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.人类口腔微生物组失调作为一种新型非侵入性生物标志物在结直肠癌检测中的应用。
Theranostics. 2020 Sep 18;10(25):11595-11606. doi: 10.7150/thno.49515. eCollection 2020.
4
Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.肠道微生物失调特征与结直肠癌变序列相关,并能提高结直肠病变的诊断效能。
J Gastroenterol Hepatol. 2020 Dec;35(12):2109-2121. doi: 10.1111/jgh.15077. Epub 2020 Jun 22.
5
Bifidobacterium adolescentis orchestrates CD143 cancer-associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling-regulated GAS1.青春双歧杆菌通过 Wnt 信号调控的 GAS1 调控 CD143 癌症相关成纤维细胞抑制结直肠肿瘤发生。
Cancer Commun (Lond). 2023 Sep;43(9):1027-1047. doi: 10.1002/cac2.12469. Epub 2023 Aug 2.
6
Altered intestinal microbiota associated with colorectal cancer.与结直肠癌相关的肠道微生物菌群改变。
Front Med. 2019 Aug;13(4):461-470. doi: 10.1007/s11684-019-0695-7. Epub 2019 Jun 28.
7
Gut microbiome of Moroccan colorectal cancer patients.摩洛哥结直肠癌患者的肠道微生物组。
Med Microbiol Immunol. 2018 Aug;207(3-4):211-225. doi: 10.1007/s00430-018-0542-5. Epub 2018 Apr 23.
8
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.果胶补充剂显著增强了用来自结直肠癌患者的肠道微生物群人源化的荷瘤小鼠的抗PD-1疗效。
Theranostics. 2021 Feb 19;11(9):4155-4170. doi: 10.7150/thno.54476. eCollection 2021.
9
Single-Cell RNA Sequencing Reveals Heterogeneity in the Tumor Microenvironment between Young-Onset and Old-Onset Colorectal Cancer.单细胞 RNA 测序揭示了青年发病和老年发病结直肠癌肿瘤微环境中的异质性。
Biomolecules. 2022 Dec 12;12(12):1860. doi: 10.3390/biom12121860.
10
Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer.粪便和组织微生物群与结直肠癌的肿瘤 T 细胞浸润和肠系膜淋巴结受累相关。
Nutrients. 2023 Jan 9;15(2):316. doi: 10.3390/nu15020316.

引用本文的文献

1
The microbiome-cancer axis as a hidden contributor to early-onset tumorigenesis.微生物群-癌症轴作为早发性肿瘤发生的一个潜在促成因素。
Med Oncol. 2025 Sep 6;42(10):464. doi: 10.1007/s12032-025-02988-8.
2
Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation.低聚半乳糖通过调节微生物群促进肠道屏障完整性并对葡聚糖硫酸钠诱导的结肠炎发挥抗炎作用。
Int J Mol Sci. 2025 Aug 18;26(16):7968. doi: 10.3390/ijms26167968.
3
Differential Analysis of Early-Onset and Late-Onset Colorectal Cancer Based on Multidimensional Evidence Integration: A Review.

本文引用的文献

1
Targeting the gut and tumor microbiota in cancer.靶向癌症中的肠道和肿瘤微生物组。
Nat Med. 2022 Apr;28(4):690-703. doi: 10.1038/s41591-022-01779-2. Epub 2022 Apr 19.
2
Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.肿瘤驻留细胞内微生物群促进乳腺癌的转移定植。
Cell. 2022 Apr 14;185(8):1356-1372.e26. doi: 10.1016/j.cell.2022.02.027. Epub 2022 Apr 7.
3
A systematic review of microbial markers for risk prediction of colorectal neoplasia.用于结直肠肿瘤风险预测的微生物标志物的系统评价。
基于多维证据整合的早发性和晚发性结直肠癌的差异分析:综述
Cancer Control. 2025 Jan-Dec;32:10732748251363337. doi: 10.1177/10732748251363337. Epub 2025 Jul 30.
4
Cancer-associated fibroblasts as mediators of tissue microenvironment remodeling in cancer.癌症相关成纤维细胞作为癌症中组织微环境重塑的介质
Curr Opin Cell Biol. 2025 Jul 14;96:102567. doi: 10.1016/j.ceb.2025.102567.
5
The Knowledge Gap in Gut Microbiome Characterization in Early-Onset Colorectal Cancer Patients: A Systematic Scoping Review.早发性结直肠癌患者肠道微生物群特征的知识差距:一项系统综述。
Cancers (Basel). 2025 May 31;17(11):1863. doi: 10.3390/cancers17111863.
6
Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, and feces in hepatocellular carcinoma.血清、胆汁和粪便中甲胎蛋白及维生素K缺乏诱导蛋白-II在肝细胞癌中的诊断价值
World J Gastrointest Oncol. 2025 May 15;17(5):105311. doi: 10.4251/wjgo.v17.i5.105311.
7
The Enteric Microbiome in Early-Onset Colorectal Cancer: A Comprehensive Review of Its Role as a Biomarker of Disease.早发性结直肠癌中的肠道微生物群:对其作为疾病生物标志物作用的全面综述
Clin Transl Gastroenterol. 2025 May 28. doi: 10.14309/ctg.0000000000000864.
8
Comparative Analysis of Microbiological Profiles and Antibiotic Resistance Genes in Subjects with Colorectal Cancer and Healthy Individuals.结直肠癌患者与健康个体的微生物学特征及抗生素耐药基因的比较分析
Pol J Microbiol. 2025 Mar 26;74(1):71-81. doi: 10.33073/pjm-2025-006. eCollection 2025 Mar 1.
9
Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer.肿瘤内微生物群:对癌症免疫调节和创新治疗策略的影响
J Biomed Sci. 2025 Feb 19;32(1):23. doi: 10.1186/s12929-025-01117-x.
10
Investigating the role of inflammatory cytokines in mediating the effect of gut microbiota on gastrointestinal cancers: a mendelian randomization study.探究炎性细胞因子在介导肠道微生物群对胃肠道癌症影响中的作用:一项孟德尔随机化研究
Gastric Cancer. 2025 May;28(3):442-454. doi: 10.1007/s10120-025-01587-w. Epub 2025 Feb 17.
Br J Cancer. 2022 May;126(9):1318-1328. doi: 10.1038/s41416-022-01740-7. Epub 2022 Mar 15.
4
CCL7 and TGF-β secreted by MSCs play opposite roles in regulating CRC metastasis in a KLF5/CXCL5-dependent manner.MSCs 分泌的 CCL7 和 TGF-β 通过 KLF5/CXCL5 依赖性途径发挥相反的作用来调节 CRC 转移。
Mol Ther. 2022 Jun 1;30(6):2327-2341. doi: 10.1016/j.ymthe.2022.03.005. Epub 2022 Mar 10.
5
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
6
Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma.肝内微生物失调诱导的肝星状细胞激活和衰老促使肝硬化向肝细胞癌进展。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003069.
7
Dysbiosis of human gut microbiome in young-onset colorectal cancer.青年期结直肠癌患者的肠道微生物群失调。
Nat Commun. 2021 Nov 19;12(1):6757. doi: 10.1038/s41467-021-27112-y.
8
Unexpected guests in the tumor microenvironment: microbiome in cancer.肿瘤微环境中的意外访客:癌症中的微生物组。
Protein Cell. 2021 May;12(5):426-435. doi: 10.1007/s13238-020-00813-8. Epub 2020 Dec 9.
9
Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.癌症与微生物组——共生微生物群对癌症、免疫反应和免疫治疗的影响。
Gastroenterology. 2021 Jan;160(2):600-613. doi: 10.1053/j.gastro.2020.11.041. Epub 2020 Nov 28.
10
Rising incidence of early-onset colorectal cancer - a call to action.结直肠癌发病年轻化——行动的召唤。
Nat Rev Clin Oncol. 2021 Apr;18(4):230-243. doi: 10.1038/s41571-020-00445-1. Epub 2020 Nov 20.